pentoxifylline inhibits vgamma9/vdelta2 t lymphocyte activation of patients with active behçet's disease

Giovanni Triolo, Francesco Ciccia, Impastato, Antonina Accardo-Palumbo, Giardina, Giovanni Triolo, Cadelo, Francesco Ciccia, Angelo Ferrante, Marcello Cadelo, Rosalia Impastato

    Risultato della ricerca: Articlepeer review

    10 Citazioni (Scopus)


    The aim ofthis study is to evaluate the in vitro effect ofpentoxifylline (PTX) on T Vy9No21ymphocytefunction in Beheet's disease (DO). We investigated the effect of PTX on Vy9No2 T cell expansion andexpression of TNFRII receptor and perforin content before and after PTX addition by means of FACSanalysis lymphocyte cultures from patients with active and inactive DO and healthy subjects. Theaddition of PTX at a concentration of 1 mg/ml determined a significant inhibition of cell expansion, adown regulation of TNF receptor expression and inhibited the PMA-induced degranulation of perforin.Taken together these data indicate that PTX is capable of interfering with Vy9No2 T cell function in DO,and although cell culture models cannot reliably predict all of the potential effects of the drug in vivo,our results encourage the possibility that this drug may find use in a range of immunological disordercharacterized by dysregulated cell-mediated immunity
    Lingua originaleEnglish
    pagine (da-a)601-606
    Numero di pagine6
    RivistaInternational Journal of Immunopathology and Pharmacology
    Stato di pubblicazionePublished - 2007

    All Science Journal Classification (ASJC) codes

    • ???subjectarea.asjc.2700.2723???
    • ???subjectarea.asjc.2400.2403???
    • ???subjectarea.asjc.3000.3004???


    Entra nei temi di ricerca di 'pentoxifylline inhibits vgamma9/vdelta2 t lymphocyte activation of patients with active behçet's disease'. Insieme formano una fingerprint unica.

    Cita questo